A Randomized Phase III Trial of SOX/Bevacizumab versus FOLFOX/Bevacizmab in Treating Patients with Metastatic Colorectal Cancer (SOFT).

Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2009
This article has no abstract
Epistemonikos ID: d436bd780b01d822368d99a229314f2356cb2cff
First added on: Apr 16, 2025